• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

端粒酶逆转录酶启动子突变在人肝胆胰和胃肠癌细胞系中的研究。

Telomerase Reverse Transcriptase Promoter Mutations in Human Hepatobiliary, Pancreatic and Gastrointestinal Cancer Cell Lines.

机构信息

Department of Gastroenterology and Neurology, Kagawa University, Kagawa, Japan.

Department of Pathology and Host-Defense, Faculty of Medicine, Kagawa University, Kagawa, Japan.

出版信息

In Vivo. 2022 Jan-Feb;36(1):94-102. doi: 10.21873/invivo.12680.

DOI:10.21873/invivo.12680
PMID:34972704
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8765179/
Abstract

BACKGROUND/AIM: The promoter region of the telomerase reverse transcriptase (TERT) gene is a regulatory element capable of affecting TERT expression, telomerase activity, and telomerase length. Mutations within the TERT promoter region are the most common mutations in many cancers. In this study, we characterized the TERT promoter mutation status in hepatobiliary, pancreatic, and gastrointestinal cancer cell lines.

MATERIALS AND METHODS

TERT promoter mutation status was assessed by digital PCR in 12 liver cancer, 5 cholangiocarcinoma (CCA), 12 pancreatic cancer, 17 gastrointestinal cancer, and 3 healthy control cell lines.

RESULTS

The C228T promoter mutation was detected in 9 liver cancer lines, and the C250T TERT mutation was detected in 1 oesophageal squamous cell carcinoma line.

CONCLUSION

The C228T promoter mutation is specific to liver cancer cell lines among various gastrointestinal cancer cell lines. These data will contribute to future research on the tumorigenic mechanisms and clinical use of digital PCR to detect mutations.

摘要

背景/目的:端粒酶逆转录酶(TERT)基因的启动子区域是一个调节元件,能够影响 TERT 表达、端粒酶活性和端粒酶长度。TERT 启动子区域内的突变是许多癌症中最常见的突变。在这项研究中,我们对肝胆胰和胃肠道癌细胞系中的 TERT 启动子突变状态进行了特征描述。

材料和方法

通过数字 PCR 评估了 12 个肝癌、5 个胆管癌(CCA)、12 个胰腺癌、17 个胃肠道癌和 3 个健康对照细胞系中的 TERT 启动子突变状态。

结果

在 9 个肝癌系中检测到 C228T 启动子突变,在 1 个食管鳞状细胞癌细胞系中检测到 C250T TERT 突变。

结论

C228T 启动子突变是各种胃肠道癌细胞系中肝癌细胞系特有的。这些数据将有助于进一步研究肿瘤发生机制以及数字 PCR 检测突变的临床应用。

相似文献

1
Telomerase Reverse Transcriptase Promoter Mutations in Human Hepatobiliary, Pancreatic and Gastrointestinal Cancer Cell Lines.端粒酶逆转录酶启动子突变在人肝胆胰和胃肠癌细胞系中的研究。
In Vivo. 2022 Jan-Feb;36(1):94-102. doi: 10.21873/invivo.12680.
2
Common telomerase reverse transcriptase promoter mutations in hepatocellular carcinomas from different geographical locations.不同地理位置肝细胞癌中常见的端粒酶逆转录酶启动子突变
World J Gastroenterol. 2015 Jan 7;21(1):311-7. doi: 10.3748/wjg.v21.i1.311.
3
Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation.在一项针对多种肿瘤类型的大规模研究中发现的复发性端粒酶逆转录酶(TERT)启动子突变与TERT表达增加和端粒酶激活有关。
Eur J Cancer. 2015 May;51(8):969-76. doi: 10.1016/j.ejca.2015.03.010. Epub 2015 Apr 2.
4
Regulatory Single Nucleotide Polymorphism Increases TERT Promoter Activity in Thyroid Carcinoma Cells.调控单核苷酸多态性可增强甲状腺癌细胞中端粒酶逆转录酶启动子活性。
Pathobiology. 2020;87(6):338-344. doi: 10.1159/000509752. Epub 2020 Nov 23.
5
TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA.TERT 启动子突变作为早期遗传事件,激活滤泡状甲状腺腺瘤(FTA)和非典型 FTA 中的端粒酶。
Cancer. 2014 Oct 1;120(19):2965-79. doi: 10.1002/cncr.28800. Epub 2014 Jun 4.
6
The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors.TERT 启动子激活突变 C228T 在肾上腺肿瘤亚群中反复出现。
Endocr Relat Cancer. 2014 May 6;21(3):427-34. doi: 10.1530/ERC-14-0016. Print 2014 Jun.
7
Telomerase reverse transcriptase promoter mutations in tumors originating from the adrenal gland and extra-adrenal paraganglia.源自肾上腺和肾上腺外副神经节的肿瘤中的端粒酶逆转录酶启动子突变
Endocr Relat Cancer. 2014 Aug;21(4):653-61. doi: 10.1530/ERC-13-0429. Epub 2014 Jun 20.
8
Distinct TERT promoter C228T and C250T mutations in a patient with an oligodendroglioma: A case report.患者患有少突胶质细胞瘤,存在 TERT 启动子 C228T 和 C250T 突变:病例报告。
Neuropathology. 2021 Jun;41(3):236-242. doi: 10.1111/neup.12727. Epub 2021 Apr 26.
9
TERT promoter mutation in adult granulosa cell tumor of the ovary.卵巢成人颗粒细胞瘤中的 TERT 启动子突变。
Mod Pathol. 2018 Jul;31(7):1107-1115. doi: 10.1038/s41379-018-0007-9. Epub 2018 Feb 15.
10
Highly prevalent TERT promoter mutations in aggressive thyroid cancers.在侵袭性甲状腺癌中普遍存在 TERT 启动子突变。
Endocr Relat Cancer. 2013 Jul 12;20(4):603-10. doi: 10.1530/ERC-13-0210. Print 2013 Aug.

引用本文的文献

1
TERT-TP53 mutations: a novel biomarker pair for hepatocellular carcinoma recurrence and prognosis.端粒酶逆转录酶-TP53突变:一种用于肝细胞癌复发和预后的新型生物标志物组合
Sci Rep. 2025 Jan 29;15(1):3620. doi: 10.1038/s41598-025-87545-z.
2
Clinicopathological and Prognostic Values of Telomerase Reverse Transcriptase () Promoter Mutations in Ovarian Clear Cell Carcinoma for Predicting Tumor Recurrence, Platinum Resistance and Survival.端粒酶逆转录酶()启动子突变在预测卵巢透明细胞癌肿瘤复发、铂类耐药和生存中的临床病理和预后价值。
Cancer Genomics Proteomics. 2023 Nov-Dec;20(6):626-636. doi: 10.21873/cgp.20411.
3
Chicken telomerase reverse transcriptase promotes the tumorigenicity of avian leukosis virus subgroup J by regulating the Wnt/β-catenin signaling pathway.鸡端粒酶逆转录酶通过调控 Wnt/β-连环蛋白信号通路促进 J 亚群禽白血病病毒的致瘤性。
Vet Res. 2022 Dec 2;53(1):100. doi: 10.1186/s13567-022-01120-2.
4
Hesperidin Inhibits Lung Cancer and Through PinX1.橙皮苷通过PinX1抑制肺癌。
Front Pharmacol. 2022 Jul 1;13:918665. doi: 10.3389/fphar.2022.918665. eCollection 2022.
5
The expression level of chicken telomerase reverse transcriptase in tumors induced by ALV-J is positively correlated with methylation and mutation of its promoter region.鸡端粒酶逆转录酶在 ALV-J 诱导的肿瘤中的表达水平与其启动子区域的甲基化和突变呈正相关。
Vet Res. 2022 Jun 23;53(1):49. doi: 10.1186/s13567-022-01069-2.

本文引用的文献

1
Telomerase Regulation: A Role for Epigenetics.端粒酶调控:表观遗传学的作用
Cancers (Basel). 2021 Mar 10;13(6):1213. doi: 10.3390/cancers13061213.
2
TERT promoter mutated circulating tumor DNA as a biomarker for prognosis in hepatocellular carcinoma.端粒酶反转录酶启动子突变的循环肿瘤 DNA 作为肝细胞癌预后的生物标志物。
Scand J Gastroenterol. 2020 Dec;55(12):1433-1440. doi: 10.1080/00365521.2020.1837928. Epub 2020 Oct 25.
3
TERT Promoter Mutation in Serum Cell-Free DNA Is a Diagnostic Marker of Primary Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease.血清游离 DNA 中端粒酶逆转录酶启动子突变是非酒精性脂肪性肝病患者原发性肝细胞癌的诊断标志物。
Oncology. 2021;99(2):114-123. doi: 10.1159/000510366. Epub 2020 Sep 30.
4
Heterogeneity of telomerase reverse transcriptase mutation and expression, telomerase activity and telomere length across human cancer cell lines cultured in vitro.人癌细胞系体外培养中端粒酶逆转录酶突变和表达、端粒酶活性和端粒长度的异质性。
Exp Cell Res. 2020 Nov 1;396(1):112298. doi: 10.1016/j.yexcr.2020.112298. Epub 2020 Sep 21.
5
Prediction of the prognosis of advanced hepatocellular carcinoma by TERT promoter mutations in circulating tumor DNA.循环肿瘤 DNA 中 TERT 启动子突变预测晚期肝细胞癌的预后。
J Gastroenterol Hepatol. 2021 Apr;36(4):1118-1125. doi: 10.1111/jgh.15227. Epub 2020 Sep 7.
6
Telomeres and Telomerase in the Development of Liver Cancer.端粒与端粒酶在肝癌发生发展中的作用
Cancers (Basel). 2020 Jul 24;12(8):2048. doi: 10.3390/cancers12082048.
7
Clinical significance of combined circulating TERT promoter mutations and miR-122 expression for screening HBV-related hepatocellular carcinoma.联合检测循环端粒酶逆转录酶启动子突变和 miR-122 表达对筛查乙型肝炎病毒相关肝细胞癌的临床意义。
Sci Rep. 2020 May 18;10(1):8181. doi: 10.1038/s41598-020-65213-8.
8
Frequency of somatic mutations in promoter, and genes in patients with hepatocellular carcinoma from Southern Italy.意大利南部肝细胞癌患者启动子及基因中体细胞突变的频率
Oncol Lett. 2020 Mar;19(3):2368-2374. doi: 10.3892/ol.2020.11332. Epub 2020 Jan 22.
9
Diverse regulatory manners of human telomerase reverse transcriptase.人类端粒酶逆转录酶的多种调控方式。
Cell Commun Signal. 2019 Jun 11;17(1):63. doi: 10.1186/s12964-019-0372-0.
10
Identification of genes involved in the regulation of TERT in hepatocellular carcinoma.鉴定参与调控肝细胞癌 TERT 的基因。
Cancer Sci. 2019 Feb;110(2):550-560. doi: 10.1111/cas.13884. Epub 2019 Jan 4.